Septic Shock Clinical Trial
— ECHODIAPHOfficial title:
Ultrasound Observation of Diaphragmatic Atrophy Related to Mechanical Ventilation A Prospective Monocentric Study in Intensive Care Unit
Verified date | April 2024 |
Source | Centre Hospitalier Saint Joseph Saint Luc de Lyon |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Ventilatory support during critical phase result in inactivity of respiratory muscles especially diaphragm muscle. These inactivity also result in change of contractile capability and quick muscular atrophy. The aim of the study is to visualize the evolution of diaphragm thickness by echography during Mechanical Ventilation for patients with septic shock or acute respiratory distress syndrome and to compare with the evolution for patients under non-invasive ventilation and those with spontaneous ventilation. Measurements will be performed at day 1, day 5 and day 10 (if patient still under a mode of ventilation or in the unit). The evolution of diaphragm thickness will also be compared to pectoralis muscle atrophy, which is not involved in ventilation, in order to assess respective effect of ventilatory inactivity and undernutrition linked to intensive care.
Status | Completed |
Enrollment | 97 |
Est. completion date | December 22, 2015 |
Est. primary completion date | December 17, 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age =18 years old - Group 1 : under Mechanical Ventilation (time of Mechanical Ventilation for at least 5 days) - Group 2 : under Non-invasive Ventilation - Group 3 : Spontaneous Ventilation - Non opposition of patient (Groups 2 and 3) or non-opposition of patient family member (Group 1) Exclusion Criteria: - Known diaphragmatic paralysis - Neurologic pathology with motor deficit - Pregnancy or breast-feeding woman |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Saint Joseph Saint Luc de Lyon |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from day 1 diaphragm thickness at day 3 and day 5 | Diaphragm thickness measured by ultrasound | 1 day, 3 days and 5 days after introduction of Mechanical Ventilation | |
Secondary | Diaphragm thickness measured by ultrasound | 10 days after introduction of Mechanical Ventilation | ||
Secondary | Type of ventilatory support | Define which type of ventilatory support is used (mechanical ventilation, non-invasive ventilation, or spontaneous ventilation) | 10 days after start of ventilatory support | |
Secondary | Ventilatory mode | Ventilatory mode (controlled ventilation, pressure support ventilation) | 10 days after start of ventilatory support | |
Secondary | Pectoralis muscle thickness measured by ultrasound | To compare the importance of this atrophy to those of diaphragmatic muscle | 10 days after start of ventilatory support | |
Secondary | Diaphragmatic strength | Relation between diaphragmatic atrophy and decrease of diaphragmatic strength | intraoperative | |
Secondary | Early or late extubation failure rate (extubation performed before or after 48 hours) | Relation between diaphragmatic atrophy importance and premature (<48h) or late extubation failure | The last day of hospitalisation | |
Secondary | MRC score (Medical Research Council) | Relation between diaphragmatic atrophy and decrease of diaphragmatic strength | intraoperative | |
Secondary | Length of ventilation in hours | 10 days after start of ventilatory support | ||
Secondary | Drug administration | Presence of drug administration such as curare, corticoid or sedative. If yes : number of days with treatment | 10 days after start of ventilatory support | |
Secondary | Total positive end expiratory pressure | 10 days after start of ventilatory support | ||
Secondary | External positive end expiratory pressure | 10 days after start of ventilatory support | ||
Secondary | Respiratory rate | 10 days after start of ventilatory support | ||
Secondary | Highest inspiratory pressure level | 10 days after start of ventilatory support | ||
Secondary | Highest expiratory pressure level | 10 days after start of ventilatory support | ||
Secondary | Volume of exhaled air | 10 days after start of ventilatory support |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03649633 -
Vitamin C, Steroids, and Thiamine, and Cerebral Autoregulation and Functional Outcome in Septic Shock
|
Phase 1/Phase 2 | |
Terminated |
NCT04117568 -
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
|
||
Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
Completed |
NCT05629780 -
Temporal Changes of Lactate in CLASSIC Patients
|
N/A | |
Recruiting |
NCT04796636 -
High-dose Intravenous Vitamin C in Patients With Septic Shock
|
Phase 1 | |
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
Recruiting |
NCT05066256 -
LV Diastolic Function vs IVC Diameter Variation as Predictor of Fluid Responsiveness in Shock
|
N/A | |
Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 | |
Not yet recruiting |
NCT04516395 -
Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae
|
N/A | |
Recruiting |
NCT02899143 -
Short-course Antimicrobial Therapy in Sepsis
|
Phase 2 | |
Recruiting |
NCT02676427 -
Fluid Responsiveness in Septic Shock Evaluated by Caval Ultrasound Doppler Examination
|
||
Recruiting |
NCT02580240 -
Administration of Hydrocortisone for the Treatment of Septic Shock
|
N/A | |
Recruiting |
NCT02565251 -
Volemic Resuscitation in Sepsis and Septic Shock
|
N/A | |
Not yet recruiting |
NCT02547467 -
TOADS Study: TO Assess Death From Septic Shock.
|
N/A | |
Completed |
NCT02638545 -
Hemodynamic Effects of Dexmedetomidine in Septic Shock
|
Phase 3 | |
Terminated |
NCT02335723 -
ASSET - a Double-Blind, Randomized Placebo-Controlled Clinical Investigation With Alteco® LPS Adsorber
|
N/A | |
Completed |
NCT02306928 -
PK Analysis of Piperacillin in Septic Shock Patients
|
N/A | |
Completed |
NCT02079402 -
Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive Care
|
Phase 4 |